Slingshot members are tracking this event:
Regeneron Pharmaceuticals (REGN) Phase 2 PD-1 antibody trial in basal cell carcimonia set to begin in 2017
Slingshot Insights Explained
Aug 03, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Basal Cell Carcinoma, Pd-1, Phase 2